Cargando...
Incorporating CDK4/6 Inhibitors in the Treatment of Advanced Luminal Breast Cancer
After optimizing endocrine monotherapy modalities in the setting of advanced luminal breast cancer (BC), dual endocrine/targeted therapy combinations have been tested with positive results, and are transforming this BC subtype treatment landscape. Cell cycle deregulation is a hallmark of cancer that...
Guardado en:
| Publicado en: | Breast Care (Basel) |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
S. Karger GmbH
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5704690/ https://ncbi.nlm.nih.gov/pubmed/29234248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000481656 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|